Skip to main content
drug protocol number
H9X-MC-GBGC
drug sponsor
Eli Lilly
drug study
Dulaglutide 0.75 /1.5 mg
drug trial site
King Khalid University Hospital (Riyadh), International Medical Center (Jeddah)
drug status
Ongoing
drug phase